CD95 ligand-expressing tumors are rejected in anti-tumor TCR transgenic perforin knockout mice

Journal of Immunology

Volumn 166, Issue 5, 2001, Pages 3240-3247

  Behrens, C K ^a   Igney, F H ^a   Arnold, B ^a   Moller P ^a   Krammer, P H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ANTIBODY; CONCANAVALIN A; FAS ANTIGEN; PERFORIN; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER INFILTRATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; IMMUNE RESPONSE; MOUSE; NATURAL KILLER CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TARGET CELL; TRANSGENIC MOUSE; TUMOR REJECTION;

EID: 0035284892     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.5.3240     Document Type: Article

References (58)

1. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells
2. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen
3. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family
4. Purification and characterization of the Fas-ligand that induces apoptosis
5. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens
6. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
7. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas
8. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation
9. Activation interferes with the APO-1 pathway in mature human T cells
10. Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes
11. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4
12. Tumor expression of Fas ligand (CD95L) and the consequences
13. Tumor counterattack - Concept and reality
14. Melanoma cell expression of Fas(Apo-1/CD95) ligand: Implications for tumor immune escape
15. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - A mechanism of immune evasion?
16. The Fas counterattack in vivo: Apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma
17. Antitumor effect of locally produced CD95 ligand
18. Gene transfer of Fas ligand induces tumor regression in vivo
19. A role for CD95 ligand in preventing graft rejection
20. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice
21. Transgenic expression of CD95 ligand on islet β cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts
22. Immune response and myoblasts that express Fas ligand
23. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction
24. Monoclonal antibodies against an H-2Kb-specific cytotoxic T cell clone detect several clone-specific molecules
25. Decreased tumor surveillance in perforin-deficient mice
26. Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction
27. Herpes simplex virus type 1 infection of activated cytotoxic T cells: Induction of fratricide as a mechanism of viral immune evasion
28. A null mutation in the perforin gene impairs cytolytic T lymphocyte- and natural killer cell-mediated cytotoxicity
29. 2+-independent T cell-mediated cytotoxicity
30. The role of the Fas lytic pathway in a perforin-less CTL hybridoma
31. Hybrids between rat lymphoma and mouse T cells with inducible cytolytic activity
32. A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity
33. The DNA sequence of the H-2Kb gene: Evidence for gene conversion as a mechanism for the generation of polymorphism in histocompatibility antigens
34. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis
35. The JAM test: A simple assay for DNA fragmentation and cell death
36. Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases
37. Über die fermentzytochemische darstellung von neutrophilen myeloischen zellen und gewebsmastzellen im paraffinschnitt
38. Chemotaxis of polymorphonuclear neutrophils (PMN) in patients suffering from recurrent infection
39. Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1 β converting enzyme
40. Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product
41. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis
42. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
43. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leukocytes
44. Tumor antigens recognized by T lymphocytes
45. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity
46. Chemotactic activity of soluble Fas ligand against phagocytes
47. Soluble Fas ligand is chemotactic for human neutrophilic polymorphonuclear leukocytes
48. Expression of the functional soluble form of human fas ligand in activated lymphocytes
49. Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-α and ligation of Fas antigen
50. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-α, LPS, and IL-1 β
51. Caspase 1-independent IL-1β release and inflammation induced by the apoptosis inducer Fas ligand
52. Opposing effects of transmembrane and soluble fas ligand expression on inflammation and tumor cell survival
53. Human neutrophil antimicrobial activity
54. 2 or products of activated neutrophils
55. A view to a kill: Cytotoxic mechanisms of human polymorphonuclear leukocytes compared with monocytes and natural killer cells
56. Phagocytic cell defects permit widespread bacterial infections
57. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii